Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Functionally specialized junctions between endothelial cells of lymphatic vessels
2007 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
Active Hexose Correlated Compound (AHCC) Enhances Resistance to Infection in a Mouse Model of Surgical Wound Infection
2006
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Antimicrobial therapy for patients with severe sepsis and septic shock: An evidence-based review
2004
Immunomodulation in the critically ill
2009
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned
2001
Dynamic Quantitative Echocardiographic Evaluation of Mitral Regurgitation in the Operating Department
2006
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
2017 Standout
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
2004 Standout
Nucleotide signalling during inflammation
2014 StandoutNature
Identification of Early Acute Lung Injury at Initial Evaluation in an Acute Care Setting Prior to the Onset of Respiratory Failure
2009
Has Mortality from Acute Respiratory Distress Syndrome Decreased over Time?
2008
Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis
2007
Drotrecogin Alfa (Activated) in Adults with Septic Shock
2012 Standout
Evaluation of an Intervention Designed to Decrease the Rate of Nosocomial Methicillin-ResistantStaphylococcus aureusInfection by Encouraging Decreased Fluoroquinolone Use
2006
Pathophysiology of Sepsis
2007
Antitumor Necrosis Factor Therapy Is Associated With Improved Survival in Clinical Sepsis Trials
2013
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome
2003 Standout
Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials
2002
Sepsis: a roadmap for future research
2015
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Severe Sepsis and Septic Shock
2013 Standout
Novel strategies for the treatment of sepsis
2003
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Immunodesign of experimental sepsis by cecal ligation and puncture
2008 Standout
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Targets for pharmacological intervention of endothelial hyperpermeability and barrier function
2002
Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients
2002
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
Sepsis and septic shock
2018 Standout
Acute respiratory distress syndrome
2019 Standout
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*
2010
Risk Factors for Persistent Carriage of Methicillin‐ResistantStaphylococcus aureus
2000
Pharmacology of Acute Lung Injury
2002
Vascular pharmacology of acute lung injury and acute respiratory distress syndrome
2002
The Pathophysiology and Treatment of Sepsis
2003 Standout
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
2020 Standout
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
The acute respiratory distress syndrome
2012 Standout
Empiric antibiotic therapy for suspected ventilator-associated pneumonia: A systematic review and meta-analysis of randomized trials
2008
The dark side of C5a in sepsis
2004
Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: Diagnosis and treatment
2008
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations
2015 Standout
Risk and the Efficacy of Antiinflammatory Agents
2002
New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
2012
Assessment of Clinical Criteria for Sepsis
2016 Standout
Increase in Methicillin-Resistant Staphylococcus aureus Acquisition Rate and Change in Pathogen Pattern Associated with an Outbreak of Severe Acute Respiratory Syndrome
2004
Acute Respiratory Distress Syndrome
2012 Standout
A2B Adenosine Receptor Blockade Enhances Macrophage-Mediated Bacterial Phagocytosis and Improves Polymicrobial Sepsis Survival in Mice
2011
Interleukin-10 Controls the Onset of Irreversible Septic Shock
2002
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Transoesophageal echocardiography in routine cardiac surgery
2004
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
Transesophageal Echocardiography and Noncardiac Surgery
2008
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
2020 Standout
Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes
2003
Works of Rainer Brase being referenced
Outbreaks of Staphylococcus aureus infections during treatment of late onset pneumonia with ciprofloxacin in a prospective, randomized study
1998
A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome
2001
The influence of transoesophageal echocardiography on intra‐operative decision makingA European multicentre study
1998
Quantification of mitral regurgitant flow using proximal isovelocity surface area method: A transesophageal echocardiography perioperative study
1998
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study
2001